Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

NCT07349225 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

ES-SCLC

Interventions

DRUG: Iparomlimab and Tuvonralimab Injection
DRUG: Etoposide
DRUG: Cisplatin
RADIATION: Targeted Radiation Therapy

Sponsor

The Second Affiliated Hospital of Dalian Medical University